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Abstract: Stress has long been known to be a causative factor of various disease states. In this study, we investigated the 
eff  ects of repeated restraint stress on platelet endothelial cell adhesion molecule-1 (PECAM-1), a very important mediator in 
inflammation, immunoreactivity and protein levels as well as neuronal damage, in the gerbil hippocampus after 5 minutes 
of transient cerebral ischemia. Transient ischemia-induced neuronal death was shown in CA1 pyramidal cells 4 days after 
ischemia/reperfusion. However, repeated restraint stress protected neuronal death induced by ischemic damage. In the 
ischemia-group, PECAM-1 immunoreactivity and its protein levels were significantly increased in all the hippocampal 
subregions 4 days after ischemia/reperfusion. However, PECAM-1 immunoreactivity and its protein levels did not change 
significantly in the hippocampus of the stress-ischemia-group compared to the sham-groups. These results indicate that 
repeated restraint stress protects neuronal damage induced by transient cerebral ischemia, and this may be associated with 
maintenance of PECAM-1levels.
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of corticosterone. In animal and human studies stress 
significantly decreases dendritic length. The number of 
branch points in hippocampal CA3 pyramidal neurons 
induces atrophy of the apical dendrites of CA3 pyramidal cells 
in the rat hippocampus, and suppresses hippocampal learning 
and memory (Watanabe et al., 1992; Magariños & McEwen, 
1995; Magariños et al., 1996; Vyas et al., 2002).
Transient occlusion of the common carotid artery deprives 
the brain of blood flow and significantly reduces glucose 
and oxygen levels. Th   is condition induces neuronal changes 
in the central nervous system. Among susceptible regions, 
the hippocampus is the most vulnerable region to cerebral 
ischemia, and extensive neuronal death occurs in this region 
(Kirino, 1982; Petito & Pulsinelli, 1984). Recent studies have 
Introduction
   
Stress, a nonspecific response of the body, has long been 
believed to be associated with various forms of diseases (Selye, 
1980). In the brain, the hippocampus is sensitive to stress and 
is one of the fi  rst regions to be structurally and functionally 
modified by severe and inescapable stress (McEwen, 2000), 
because the hippocampus is one of the target brain regions PECAM-1 in ischemic hippocampus
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identifi  ed infl  ammation as a possible mechanism in neuronal 
damage induced by cerebral ischemia because infl  ammatory 
cells are known to infi  ltrate the ischemic brain area (Gautier 
et al., 2009; Hendryk et al., 2010). In addition, some studies 
have shown that stress leads to an exacerbation of stroke 
outcomes (DeVries et al., 2001: Sugo et al., 2002). In contrast, 
others reported that stress reduced brain damage after an 
ischemic insult (Th  oresen  et al., 1996).
Platelet endothelial cell adhesion molecule-1 (PECAM-1, 
CD31) is a very important mediator in inflammation; it 
contributes to leukocyte transendothelial migration during 
inflammation (Muller & Randolph, 1999; O’Brien et al., 
2003). PECAM-1 levels increase significantly in serum 
and cerebrospinal fluid of patients within 24 hours after 
an ischemic stroke (Zaremba & Losy, 2002b). In addition, 
PECAM-1 immunoreactivity and protein levels have been 
shown to be significantly increased in the hippocampal 
CA1 region 4 days after ischemia/reperfusion (Hwang et 
al., 2005). Th   e elevation of PECAM-1 in vessels is known to 
increase the transmigration of lymphocytes and neutrophils 
(Dangerfield et al., 2002; Michiels et al., 1998). Infiltrative 
neutrophils and monocytes produce neural toxic substances 
and contribute to neuronal damage following ischemic 
stroke (Wang et al., 2002; Deng et al., 2003; Gidday et al., 
2005). In addition, inflammation by infiltration of activated 
neutrophils and microglia is known as a major contributor 
of secondary neuronal death after a stroke (Iadecola & 
Alexander, 2001; Zheng et al., 2003; Williams et al., 2004). 
However, to date there are no studies documenting the 
relationship between stress and PECAM-1 expression in the 
brain aft  er an ischemic insult. Th   erefore, in the present study, 
we investigated the effects of stress on ischemic damage, 
and PECAM-1 immunoreactivity and protein levels in the 
gerbil hippocampus following 5 minutes of transient cerebral 
ischemia.
   
   
Materials and Methods
Experimental animals
Th   e progeny of male Mongolian gerbils (Meriones ungui-
culatus) were obtained from the Experimental Animal Center, 
Hallym University, Chuncheon, South Korea. Gerbils were 
used at 6 months (B.W., 65~75 g) of age. Th   e animals were 
housed in a conventional state under adequate temperature 
(23
oC) and humidity (60%) control with a 12-h light/12-h 
dark cycle, and provided with free access to water and 
food. The procedures for handling animals and their care 
conformed to the guidelines that are in compliance with 
current international laws and policies (NIH Guide for 
the Care and Use of Laboratory Animals, NIH Publication 
No. 85~23, 1985, revised 1996) and were approved by the 
Hallym’s Medical Center Institutional Animal Care and Use 
Committee (IACUC). All of the experiments were conducted 
to minimize the number of animals used and suff  ering caused 
by such procedures.
   
Induction of repeated restraint stress
The restraint stress cages were consisted of adjustable 
length (12.0~2.0 cm length and 3.8 cm diameter) Plexi-
glass tubes with air holes in the front, top and back. Gerbils 
were divided into two groups; control- and repeated restraint 
stress (stress)-groups. Control-group was left untouched in 
their home cages until the ischemic surgery. Stress-group 
was placed into restrainers for 5 hours (between 09:30 h and 
14:30 h) for 21 consecutive days prior to the ischemic surgery. 
Finally, experimental groups were divided into 4 groups; 1) 
sham-operated control-group (sham-group), 2) ischemia-
operated control-group (ischemia-group), 3) sham-operated 
stress-group (stress-sham-group), 4) ischemia-operated 
stress-group (stress-ischemia-group).
   
Induction of transient cerebral ischemia
The animals in both control and stress groups were 
anesthetized with a mixture of 2.5% isoflurane (Baxtor, 
Deerfi  eld, IL) in 33% oxygen and 67% nitrous oxide. Bilateral 
common carotid arteries were isolated and occluded using 
non-traumatic aneurysm clips. The complete interruption 
of blood flow was confirmed by observing the central 
artery in retinae using an ophthalmoscope. After 5 minutes 
of occlusion, the aneurysm clips were removed from the 
common carotid arteries. The body (rectal) temperature 
under free-regulating or normothermic (37±0.5
oC) conditions 
was monitored with a rectal temperature probe (TR-100; 
Fine Science Tools, Foster City, CA) and maintained using 
a thermometric blanket before, during and aft  er the surgery 
until the animals completely recovered from anesthesia. 
Th  ereaft  er, animals were kept on the thermal incubator (Mirae 
Medical Industry, Seoul, South Korea) to maintain the body 
temperature of animals until the animals were euthanized. 
Sham-operated animals were subjected to the same surgical 
procedures except that the common carotid arteries were not Anat Cell Biol 43:54~63, 2010 Ok Kyu Park, et al 56
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occluded.
Tissue processing for histology
For the histological analysis, animals were anesthetized 
with sodium pentobarbital (30 mg/kg, i.p.) and perfused 
transcardially with 0.1 M phosphate-buff  ered saline (PBS, pH 
7.4) followed by 4% paraformaldehyde in 0.1 M phosphate-
buff  er (PB, pH 7.4). Th   e brains were removed and postfi  xed 
in the same fixative for 6 hours. The brain tissues were 
cryoprotected by infiltration with 30% sucrose overnight. 
Th  ereaft  er, frozen tissues were serially sectioned on a cryostat 
(Leica, Wetzlar, Germany) into 30-μm coronal sections, and 
they were then collected into six-well plates containing PBS.
   
Cresyl violet staining
To examine the delayed neuronal death in the hippocampal 
CA1 region after transient cerebral ischemia, cresyl violet 
staining was performed. The sections were mounted on 
gelatin coated microscopic slides. Cresyl violet acetate (Sigma, 
St. Louis, MO) was dissolved at 1.0% (w/v) in distilled water, 
and glacial acetic acid was added in this solution. Th  e  sections 
were stained and dehydrated by immersing in serial ethanol 
baths, and they were then mounted with Canada balsam 
(Kanto, Tokyo, Japan).
   
Immunohistochemical staining for PECAM-1
To obtain the accurate data for PECAM-1 immuno-
reactivity, the sections from sham- and ischemia-operated 
animals in both control and stress groups (n=7 at each time 
point) were used at designated times (1, 2 and 4 days) after 
the ischemic surgery under the same conditions. Th  e  sections 
were sequentially treated with 0.3% hydrogen peroxide 
(H2O2) in PBS for 30 minutes and 10% normal goat serum in 
0.05 M PBS for 30 minutes. They were next incubated with 
diluted mouse anti-PECAM-1 antibody (diluted 1 : 1,000, sc-
1506, Santa Cruz Biotechnology, Santa Cruz, CA) overnight 
at 4
oC and subsequently exposed to biotinylated goat anti-
mouse IgG and streptavidin peroxidase complex (diluted 1 : 
200, Vector, Burlingame, CA). And they were visualized by 
staining with 3,3’-diaminobenzidine (Sigma, St. Louis, MO) 
in 0.1 M Tris-HCl buff  er (pH 7.2) and mounted on gelatin-
coated slides. After dehydration the sections were mounted 
with Canada balsam (Kanto, Tokyo, Japan). A negative 
control test was carried out using pre-immune serum instead 
of primary antibody in order to establish the specifi  city of the 
immunostaining. Th   e negative control resulted in the absence 
of immunoreactivity in all structures.
All measurements were performed in order to ensure 
objectivity in blind conditions, by two observers for each 
experiment, carrying out the measures of control and 
experimental samples under the same conditions.
Ten sections per animal were serially selected from 
the corresponding areas of the hippocampus in order to 
quantitatively analyze PECAM-1 immunoreactivity in this 
region. Th   e studied tissue sections were selected according to 
anatomical landmarks corresponding to AP -1.4~-1.8 mm 
of gerbil brain atlas (Loskota et al., 1974). Th  e  corresponding 
areas of the hippocampus were measured on the monitor 
at a magnification of 25~50×. Images of all PECAM-1 
immunoreactive structures, taken from 3 layers (strata 
oriens, pyramidale and radiatum in the hippocampal CA1-3 
regions and polymorphic, molecular and granule cell layer in 
the dentate gyrus), were obtained through an AxioM1 light 
microscope (Carl Zeiss, Göttingen, Germany) equipped with 
a digital camera (Axiocam, Carl Zeiss, Göttingen, Germany) 
connected to a PC monitor. Th   e immunostaining density of 
all PECAM-1 immunoreactive structures was evaluated on 
the basis of a optical density (OD), which was obtained aft  er 
the transformation of the mean gray level using the formula: 
OD=log (256/mean gray level). The OD of background was 
taken from areas adjacent to the measured area. After the 
background density was subtracted, a ratio of the optical 
density of image file was calibrated as % (relative optical 
density, ROD) using Adobe Photoshop version 8.0 and then 
analyzed using NIH Image 1.59 soft  ware.
   
Western blot analysis for PECAM-1
To confirm changes in PECAM-1 levels in the 
hippocampus following transient cerebral ischemia, sham- 
and ischemia-operated animals in both control and stress 
groups (n=7 at each time point) were used for western blot 
analysis at 4 days aft  er ischemia/reperfusion. Aft  er sacrifi  cing 
animals, the hippocampus was removed. The tissues were 
homogenized in 50 mM PBS (pH 7.4) containing 0.1 
mM ethylene glycol bis (2-aminoethyl Ether)-N,N,N’,N’ 
tetraacetic acid (EGTA) (pH 8.0), 0.2% Nonidet P-40, 10 
mM ethylendiamine tetraacetic acid (EDTA) (pH 8.0), 15 
mM sodium pyrophosphate, 100 mM β-glycerophosphate, 
50 mM NaF, 150 mM NaCl, 2 mM sodium orthovanadate, 
1 mM phenylmethylsulfonyl fluoride (PMSF) and 1 mM 
dithiothreitol (DTT). After centrifugation, the protein level 
was determined in the supernatants using a Micro BCA PECAM-1 in ischemic hippocampus
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Fig. 1. CV staining in the sham- (A and B), ischemia- (C and D), stress-sham- (E and F) and stress-ischemia- (G and H) groups. Only a few CV
+ 
cells are detected in the stratum pyramidale (SP) 4 days aft  er ischemia/reperfusion (I/R) in the ischemia-group. However, in the stress-ischemia-
group, many CV
+ cells are found in the SP 4 days aft  er I/R. CA, conus ammonis; DG, dentate gyrus; SO, stratum oriens; SR, stratum radiatum. 
Bar = 800 μm (A, C, E and G), 50 μm (B, D, F and H).
protein assay kit with bovine serum albumin as the standard 
(Pierce Chemical, Rockford, IL). Aliquots containing 20 μg 
of total protein were boiled in loading buff  er containing 150 
mM Tris (pH 6.8), 3 mM DTT, 6% SDS, 0.3% bromophenol 
blue and 30% glycerol. The aliquots were then loaded onto 
a 10% polyacrylamide gel. After electrophoresis, the gels Anat Cell Biol 43:54~63, 2010 Ok Kyu Park, et al 58
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were transferred to nitrocellulose transfer membranes (Pall 
Crop, East Hills, NY). To reduce background staining, the 
membranes were incubated with 5% non-fat dry milk in 
PBS containing 0.1% Tween 20 for 45 minutes, followed by 
incubation with mouse anti-PECAM-1 antiserum (1 : 2,000), 
peroxidase-conjugated goat anti-mouse IgG (Sigma, St. Louis, 
MO) and an ECL kit (Pierce Chemical, Rockford, IL).
The result of the western blot analysis was scanned, and 
densitometric analysis for the quantifi  cation of the bands was 
done using Scion Image software (Scion Corp., Frederick, 
MD), which was used to count relative optical density (ROD): 
A ratio of the ROD was calibrated as %, with sham-group 
designated as 100%.
   
Fig. 2. Relative analysis of the number of CV
+ cells 4 days after I/
R (*P<0.05, significantly different from the sham-groups, 
†P<0.05, 
signifi  cantly diff  erent from the ischemia-group). Bars indicate means± 
SEM.
Fig. 3. Immunohistochemical staining for PECAM-1 in the CA1 region (A~D), CA2/3 region (E and F) and dentate gyrus (G and H) in the 
sham- (A and B) and ischemia-operated (C~H) gerbils of the control- (A, C, E and G) and stress- (B, D, F and H) groups 4 days after I/R. 
PECAM-1 immunoreaction (arrows) is detected in blood vessels located in strata oriens (SO) and radiatum (SR) in both the sham-groups (A and B). 
PECAM-1 immunoreactivity in the ischemia-group is markedly increased 4 days aft  er I/R (C). However, in the stress-ischemia-group, PECAM-1 
immunoreactivity is much lower than that in the ischemia-group (D). Immunohistochemical staining pattern for PECAM-1 in the CA2/3 region 
and dentate gyrus is similar to that in the CA1 region. SP, stratum pyramidale; ML, molecular layer; GCL, granule cell layer; PL, polynmorphic 
layer. Bar=50 μm.PECAM-1 in ischemic hippocampus
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Statistical analysis
The data shown here represent the means±SEM. 
Differences among the means were statistically analyzed 
by two-tailed Student t-test in order to elucidate the effects 
of repeated restraint stress against ischemic damage. In 
addition, differences of the mean ROD among the groups 
were statistically analyzed by analysis of variance (ANOVA) 
followed by Tukey’s multiple range method in order to 
elucidate ischemia-related differences among experimental 
groups. Statistical signifi  cance was considered at p<0.05.
   
   
Results
Neuronal damage
Th  e  eff  ect of repeated restraint stress on delayed neuronal 
death in the hippocampal CA1 region 4 days aft  er ischemia/
reperfusion was examined by cresyl violet staining. In the 
sham- and stress-sham groups, cresyl violet (CV) positive 
(
+) cells were distributed normally in the subregions of the 
Fig. 3. Continued.
gerbil hippocampal formation including the hippocampal 
CA1 region (Fig. 1A, B, E, F, 2). Four days after ischemia/
reperfusion, in the ischemia-group, only a few of CV
+ cells 
were detected in the stratum pyramidale of the hippocampal 
CA1 region due to the delayed neuronal death; however, 
we could not find significant neuronal damage in the other 
subregions such as the CA2/3 region and dentate gyrus (Fig. 
1C, D, 2). In the stress-ischemia-group, most of neurons in 
the hippocampal formation were stained with CV (Fig. 1G, H); 
about 82.2% of pyramidal neurons in the hippocampal CA1 
region were stained with CV (Fig. 2).
Changes in PECAM-1 immunoreactivity
In the sham- and stress-sham-groups, PECAM-1 immuno-
reaction was detected in blood vessels, located mainly in 
the stratum oriens and radiatum of the CA1-3 region (Fig. 
3A, B) and in the molecular and polymorphic layers of the 
dentate gyrus (data not shown). In both the ischemia- and 
stress-ischemia-groups, PECAM-1 immunoreactivity was not 
changed signifi  cantly until 2 days aft  er ischemia/reperfusion Anat Cell Biol 43:54~63, 2010 Ok Kyu Park, et al 60
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(data not shown). Four days after ischemia/reperfusion, 
PECAM-1 immunoreactivity was significantly increased in 
the ischemia-groups (Fig. 3C, E, G, 4). However, PECAM-1 
immunoreactivity in the CA2/3 region and dentate gyrus was 
lower than that in the CA1 region (Fig. 4). At this time point 
after ischemia/reperfusion, PECAM-1 immunoreactivity in 
the stress-ischemia-group was much lower than that in the 
ischemia-group, and was similar to that in the sham-groups 
(Fig. 3D, F, H, 4).
   
Changes in PECAM-1 protein levels   
In the western blot study, we found that changes in 
PECAM-1 protein levels in the gerbil hippocampus 
after ischemia/reperfusion were generally similar to the 
immunohistochemical change. PECAM-1 protein levels were 
similar between the sham- and stress-sham-groups. Four 
days aft  er ischemia/reperfusion, PECAM-1 protein level was 
significantly increased in the ischemia-group: PECAM-1 
protein level was increased to about 340% of that in the 
sham-group. However, there was no significant increase on 
PECAM-1 protein level in the stress-ischemia-group: it was 
similar to that in the sham-group (Fig. 5).
   
Discussion
   
In this study, we observed that repeated restraint stress 
protected ischemia-related neuronal death in the hippo-
campal CA1 region after ischemia/reperfusion. Previous 
studies showed the relationship between stress and neuronal 
damage following ischemic insults. In a permanent focal 
cerebral ischemic rat model of subacute immobilization stress 
(1 hour for 7 days), infarct size increased and behavioral 
scores decreased, whereas chronic stress (6 hours for 21 
days) decreased infarct size (Madrigal et al., 2003). It is also 
known that repeated short-term stress (45 minutes for 7days) 
induces vulnerability to neuronal damage following middle 
cerebral artery occlusion (Sugo et al., 2002). It has also been 
reported that repeated stress increases the vulnerability of 
hippocampal cells in an in vitro model of ischemia (Fontella et 
al., 2005). Although there are some discrepancies, our results 
are supported by the findings of previous studies which 
showed that repeated restraint stress protected brain damage 
Fig. 4. Relative optical density as % of PECAM-1 immuno-
reactive structures in the sham-, ischemia-, stress-sham-, and 
stress-ischemia-groups (*P<0.05, signifi  cantly diff  erent from 
the sham-group, 
†P<0.05, significantly different from the 
ischemia-group). Bars indicate means±SEM.
Fig. 5. (A) Western blot analysis of PECAM-1 (approximately 130 
kDa) 4 days aft  er I/R. (B) Relative optical density as % of immunoblot 
band is represented (*P<0.05, significantly different from the sham-
group, 
†P<0.05, signifi  cantly diff  erent from the ischemia-group). Bars 
indicate means±SEM.PECAM-1 in ischemic hippocampus
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induced by an ischemic insult. Additionally, it is well known 
that repeated same stress can lead to a process of adaptation 
to stress-induced changes (Martí et al., 1993; Lachuer et al., 
1994; Cancela et al., 1995).
In the present study, we observed the changes of PECAM-1 
immunoreactivity and protein levels in the hippocampus of 
control- and stress-groups after transient cerebral ischemia. 
In the ischemia-group, both PECAM-1 immunoreactivity 
and protein levels were significantly increased in all the 
hippocampal subregions 4 days after ischemia/reperfusion. 
This result coincided with a previous study which reported 
that PECAM-1 immunoreactivity and protein levels were 
signifi  cantly increased in the hippocampal CA1 region 4 days 
aft  er ischemia/reperfusion (Hwang et al., 2005). Th   is may be 
associated with neutrophil transmigration because PECAM-1 
plays an important role in the adhesion cascade leading to 
leukocyte-endothelial transmigration and extravasation of 
PECAM-1 producing cells, such as neutrophils, monocytes, 
and lymphocytes during infl  ammation (Ilan & Madri, 2003; 
Kalinowska & Losy, 2006). It has also been reported that 
serum PECAM-1 levels were signifi  cantly elevated in stroke 
patients (Zaremba & Losy, 2002a, b). In addition, we observed 
a considerable increase of PECAM-1 immunoreactivity 
in the CA1 region of the ischemia-group, compared to a 
moderate increase in the CA2/3 region and dentate gyrus. 
Kirino (1982) reported that different types of neuronal 
damage were observed in the CA1 region, CA2/3 region, and 
dentate gyrus aft  er transient cerebral ischemia in gerbils. Th  e 
changes in the CA1, CA2/3, and dentate gyrus were termed 
delayed neuronal death, reactive change, and ischemic cell 
change, respectively. Th   e degree of increase in PECAM-1 may 
therefore be associated with the regional vulnerability post 
transient cerebral ischemia.
However, in this study, we observed that PECAM-1 immu-
no  reactivity and protein levels did not change in the hippo-
campus of the stress-ischemia-group. It was reported that 
restraint stress, in itself, did not induce inflammatory cyto-
kines in the periphery or brain (Maier et al., 1999; Deak et 
al., 2003, 2005; Sugama et al., 2007). In addition, it has been 
shown in a rat myocardial infarction model that blocking 
PECAM-1 exerts a significant protective effect via blockade 
of neutrophil accumulation in the myocardium, and that 
anti-PECAM-1 antibodies suppress neutrophil accumulation 
into the inflamed peritoneum of rats (Vaporciyan et al., 
1993; Gumina et al., 1996). PECAM-1 antibodies also 
block transendothelial migration of leukocytes (Muller et 
al., 1993; Muller, 1995) and reduce the platelet adhesion/
aggregation in vivo at the site of endothelial injury in brain 
arterioles (Rosenblum et al., 1994). Moreover, PECAM-1-
deficient mice are viable but exhibit defects in angiogenesis 
and inflammation (Duncan et al., 1999; Thompson et al., 
2001; Graesser et al., 2002; Solowiej et al., 2003; Schenkel 
et al., 2004). As mentioned previously, inflammation and 
infi  ltration of infl  ammatory cells are thought to be important 
factors in ischemia-induced neuronal damage (Gautier et al., 
2009; Hendryk et al., 2010); therefore, the fact that there were 
no significant changes in PECAM-1 immunoreactivity and 
protein levels in the stress-ischemia-group may be related to 
the blockade of inflammatory events such as infiltration of 
infl  ammatory cells.
In conclusion, repeated restraint stress protected transient 
ischemia-induced neuronal death and maintained PECAM-1 
immunoreactivity and protein levels in the hippocampus 
following ischemia/reperfusion. Th   ese results indicate that the 
fact that we detected no signifi  cant changes in PECAM-1 may 
be connected to the effects of repeated restraint stress and 
ischemic damage.
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